21/03/2022
Did you know that the first cord blood transplant was done more than 30 years ago? The recipient was a 5-year-old boy with Fanconi anaemia (2015, Parent’s Guide to Cord Blood). This successful transplant had shifted the world’s interest to cord blood stem cells. Although globally the interest has always been higher, stem cell banking is still an alien topic in Malaysia even up until 2001, when StemLife was founded. How exactly did the two founders of StemLife, who happened to be such powerful women, make StemLife known to Malaysians just a few years after the establishment?😍 This International Women’s Day, let’s celebrate the success and career development of these two founders together with the rest of StemLife’s women workers in forging innovation😎
StemLife is a biotech company that was founded by Dato’ Low Su-Shing and Dato’ Christina Lim Oi Wah in 2001. Dato’ Sharon and Dato’ Christina Lim were 34 and 56 years old respectively when they were appointed as Executive Directors. They took the opportunity to set up a company in a very niche industry yet very crucial for the advancement of science, technology and healthcare in Malaysia. These women embraced the challenges in pioneering the cord blood preservation and stem cell technology industry, with StemLife being the first private cord blood bank licensed by the Ministry of Health💪😍. StemLife became very successful with 5000 UCB stored in only 4 years after establishment and was awarded the Bionexus status in 2006🌟
Bionexus is an exclusive status awarded only to qualified international and Malaysian biotechnology companies. StemLife has been one of the qualified companies that were noted as a company that adds value to biotechnology and life sciences activities. Being a Bionexus status company, StemLife, was one of the 5 top-performing companies within 3 years after the award, with a market capitalization of RM 100.65 million and played a role in contributing to 2.2% rate of Bionexus annual contribution to GDP😎 Listed under healthcare industry sector, StemLife has played a role in contributing to the country’s growth of employees and knowledge worker (2009, BiotechCorp). As of this year, we have 14 knowledge workers retained over the years. StemLife has always provided equal opportunities for their employee, such that we have a balanced amount of male and female workers in various departments and provide equal chances for development. To add, a lot of top management positions have been garnered by women in StemLife and up until today, the proportion of female to male workers are 72% and 28% respectively😍
StemLife's story inspires women to take charge in what they believe in💓As for Dato’ Sharon and Dato’ Christina, they beat the odds when they decided to run a company in a very niche industry. And they have empowered women to play a leading role, back then and now💪🌟
Did you know that the first cord blood transplant was done more than 30 years ago?😱 The recipient was a 5-year-old boy with Fanconi anaemia (2015, Parent’s Guide to Cord Blood). This successful transplant had shifted the world’s interest to cord blood stem cells. Although globally the interest has always been higher, stem cell banking is still an alien topic in Malaysia even up until 2001, when StemLife was founded. How exactly did the two founders of StemLife, who happened to be such powerful women, make StemLife known to Malaysians just a few years after the establishment?😍 This International Women’s Day, let’s celebrate the success and career development of these two founders together with the rest of StemLife’s women workers in forging innovation😎
StemLife is a biotech company that was founded by Dato’ Low Su-Shing and Dato’ Christina Lim Oi Wah in 2001. Dato’ Sharon and Dato’s Christina Lim were 34 and 56 years old respectively when they were appointed as Executive Directors. They took the opportunity to set up a company in a very niche industry yet very crucial for the advancement of science, technology and healthcare in Malaysia. These women embraced the challenges in pioneering the cord blood preservation and stem cell technology industry, with StemLife being the first private cord blood bank licensed by the Ministry of Health💪😍. StemLife became very successful with 5000 UCB stored in only 4 years after establishment and was awarded the Bionexus status in 2006🌟
Bionexus is an exclusive status awarded only to qualified international and Malaysian biotechnology companies. StemLife has been one of the qualified companies that were noted as a company that adds value to biotechnology and life sciences activities. Being a Bionexus status company, StemLife, was one of the 5 top-performing companies within 3 years after the award, with a market capitalization of RM 100.65 million and played a role in contributing to 2.2% rate of Bionexus annual contribution to GDP😎 Listed under healthcare industry sector, StemLife has played a role in contributing to the country’s growth of employees and knowledge worker (2009, BiotechCorp). As of this year, we have 14 knowledge workers retained over the years. StemLife has always provided equal opportunities for their employee, such that we have a balanced amount of male and female workers in various departments and provide equal chances for development. To add, a lot of top management positions have been garnered by women in StemLife and up until today, the proportion of female to male workers are 72% and 28% respectively😍
StemLife's story inspires women to take charge in what they believe in💓As for Dato’ Sharon and Dato’ Christina, they beat the odds when they decided to run a company in a very niche industry. And they have empowered women to play a leading role, back then and now💪🌟
